Connection

Roberto Caporali to Drug Substitution

This is a "connection" page, showing publications Roberto Caporali has written about Drug Substitution.
Connection Strength

0.537
  1. Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. Int J Rheum Dis. 2018 Feb; 21(2):422-430.
    View in: PubMed
    Score: 0.537
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.